Treatment of human granulocytic ehrlichiosis during pregnancy and risk of perinatal transmission.
A pregnant woman from Nantucket Island, MA was diagnosed with human granulocytic ehrlichiosis at 34 weeks gestation. We describe the diagnostic and therapeutic dilemmas involved and discuss the risks of perinatal transmission.
Casau
Nathalie C
NC
Beth Israel Deaconess Medical Center, Division of Infectious Diseases, Harvard Medical School, Boston, MA, USA. nathalie.casau@nbhn.net
Hewins
Mary Ellen
ME
Zaleznik
Dori F
DF
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001942:Breast Feeding; D004318:Doxycycline / Q000627:therapeutic use; D016873:Ehrlichiosis / Q000188:drug therapy* / Q000635:transmission*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D004318:Doxycycline